Eisele Jeffrey (CIK 1827326) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-01-30). Recent activity: Sell APLS (278 shares), Sell APLS (1,291 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-30 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Development Officer | Sell | 278 | $8,207 |
| 2025-01-23 | Apellis Pharmaceuticals, Inc. (APLS) | Chief Development Officer | Sell | 1,291 | $39,285 |
Source: SEC Form 4 filings · as of 2025-01-30